The Outcomes of Switching from Short- to Long-Term Intravitreal Corticosteroid Implant Therapy in Patients with Diabetic Macular Edema | Zendy

Sara Vaz-Pereira | Zendy; João Paulo Castro Sousa | Zendy; David Martins | Zendy; Joaquim Canelas | Zendy; Pedro Augusto Costa Reis | Zendy; António Sampaio Soares | Zendy; Helena Urbano | Zendy; P Kaku | Zendy; João Nascimento | Zendy; Carlos MarquesNeves | Zendy

Open Access

The Outcomes of Switching from Short- to Long-Term Intravitreal Corticosteroid Implant Therapy in Patients with Diabetic Macular Edema

Author(s) -

Sara Vaz-Pereira,

João Paulo Castro Sousa,

David Martins,

Joaquim Canelas,

Pedro Augusto Costa Reis,

António Sampaio Soares,

Helena Urbano,

P Kaku,

João Nascimento,

Carlos MarquesNeves

Publication year - 2019

Publication title -

ophthalmic research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.893

H-Index - 54

eISSN - 1423-0259

pISSN - 0030-3747

DOI - 10.1159/000503036

Subject(s) - medicine , fluocinolone acetonide , ophthalmology , intraocular pressure , diabetic macular edema , macular edema , implant , dexamethasone , diabetic retinopathy , visual acuity , corticosteroid , diabetes mellitus , surgery , endocrinology

The FAc intravitreal implant is effective in patients previously treated with short-term corticosteroid implants. Thus, after a suboptimal response to antiangiogenics or a short-term corticosteroid, a single FAc implant may be considered an effective and tolerable treatment that can improve long-term outcomes for patients with sight-threatening DME.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research